Pfizer Builds on the Genedata Biopharma E2E Workflow Platform


After an aborted attempt with a develop-as-you-go approach, Pfizer decided to evaluate the market in search of a commercial enterprise data management system for their large-molecule R&D groups. Pfizer chose the Genedata platform to serve as a central data backbone and application environment upon which they could build tools to flexibly address Pfizer-specific requirements and to drive innovation. After only four years, the system is now used by more than 250 people in 15 groups located at 6 Pfizer R&D sites around the globe and supports 200+ distinct projects.



Back to list